RUA Life Sciences Plc RUA
LSE · United Kingdom · Health Technology
GBp 28.00-1.00 (-3.45%)
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
The United Kingdom's FTSE 100 index recently experienced a downturn, impacted by weak trade data from China, highlighting the interconnectedness of global markets. In such fluctuating conditions, investors might consider exploring penny stocks—a term that may seem outdated but still signifies potential growth opportunities in smaller or newer companies. When these stocks are supported by robust financial health, they can offer unique investment prospects with an appealing mix of affordability...
Key Insights RUA Life Sciences' estimated fair value is UK£0.14 based on 2 Stage Free Cash Flow to Equity RUA Life...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.